Skip to main content

Table 1 Beneficial and non-beneficial OLP identified in Lima clade B cohort (p < 0.05)

From: Definition of the viral targets of protective HIV-1-specific T cell responses

OLP #

Protein

Sub-unit

OLP clade B

consensus

sequence

Median viral

load in OLP

responders

Median viral

load in OLP

non-responders

Protective Ratio

(PR)*

p-value

3

Gag

p17

EKIRLRPGGKKKYKLKHI

22947

39014

1.053

0.037

6

Gag

p17

ASRELERFAVNPGLL

15380

43189

1.107

0.001

7

Gag

p17

ERFAVNPGLLETSEGCR

25939

38974

1.040

0.049

10

Gag

p17

QLQPSLQTGSEELRSLY

16285

37237

1.085

0.031

12

Gag

p17

SLYNTVATLYCVHQRIEV

23855

37113

1.044

0.037

23

Gag

p24

AFSPEVIPMFSALSEGA

22947

37113

1.048

0.036

31

Gag

p24

IAPGQMREPRGSDIA

3563

35483

1.281

0.028

34

Gag

p24

STLQEQIGWMTNNPPIPV

6127

37360

1.207

0.002

48

Gag

p24

ACQGVGGPGHKARVLAEA

12975

35755

1.107

0.041

60

Gag

p15

GKIWPSHKGRPGNFLQSR

16266

36434

1.083

0.044

75

Nef

-

WLEAQEEEEVGFPVRPQV

13407

37360

1.108

0.026

76

Nef

-

EVGFPVRPQVPLRPMTYK

59618

29855

0.937

0.001

84

Nef

-

NYTPGPGIRYPLTFGWCF

55402

30538

0.945

0.006

85

Nef

-

RYPLTFGWCFKLVPV

69890

29903

0.924

0.002

90

Nef

-

SLHGMDDPEKEVLVWKF

89687

32650

0.911

0.042

159

Pol

Pro

KMIGGIGGFIKVRQYDQI

14736

36434

1.094

0.020

160

Pol

Pro

FIKVRQYDQILIEICGHK

3682

35755

1.277

0.031

161

Pol

Pro

QILIEICGHKAIGTVLV

9117

35483

1.149

0.050

163

Pol

Pro

LVGPTPVNIIGRNLLTQI

25965

45637

1.055

0.007

171

Pol

RT

LVEICTEMEKEGKISKI

1865

35483

1.391

0.014

181

Pol

RT

LDVGDAYFSVPLDKDFRK

65858

32871

0.937

0.041

195

Pol

RT

LRWGFTTPDKKHQKEPPF

5624

37113

1.219

0.006

196

Pol

RT

DKKHQKEPPFLWMGYELH

10103

35483

1.136

0.044

210

Pol

RT

EIQKQGQGQWTYQIY

18155

35483

1.068

0.045

222

Pol

RT

PPLVKLWYQLEKEPIVGA

412599

34640

0.808

0.030

230

Pol

RT

IHLALQDSGLEVNIV

85102

34117

0.919

0.030

237

Pol

RT

VYLAWVPAHKGIGGNEQV

85102

34117

0.919

0.029

240

Pol

RT

SAGIRKVLFLDGIDKA

116902

32761

0.891

0.019

269

Pol

Int

TKELQKQITKIQNFRVYY

6629

35755

1.192

0.030

270

Pol

Int

TKIQNFRVYYRDSRDPLW

18171

37360

1.073

0.019

271

Pol

Int

YYRDSRDPLWKGPAKLLW

25939

35755

1.032

0.043

276

Pol

Int

KIIRDYGKQMAGDDCVA

6629

35755

1.192

0.021

279

Vpr

-

GPQREPYNEWTLELLEEL

60222

32650

0.944

0.042

307

Env

Gp120

DLNNNTNTTSSSGEKMEK

179419

34117

0.863

0.044

311

Env

Gp120

IRDKVQKEYALFYKLDVV

179419

32871

0.860

0.008

314

Env

Gp120

YRLISCNTSVITQACPKV

58206

31273

0.943

0.008

315

Env

Gp120

SVITQACPKVSFEPIPIH

61011

32871

0.944

0.034

320

Env

Gp120

TNVSTVQCTHGIRPVV

341587

34640

0.820

0.034

355

Env

Gp120

VAPTKAKRRVVQREKRAV

161602

34117

0.870

0.042

399

Env

Gp41

VIEVVQRACRAILHIPRR

388089

34640

0.812

0.026

405

Vif

-

VKHHMYISGKAKGWFYRH

16458

37237

1.084

0.021

406

Vif

-

GKAKGWFYRHHYESTHPR

16458

37237

1.084

0.022

424

Vif

-

TKLTEDRWNKPQKTKGHR

10319

36434

1.137

0.014

  1. * PR values in bold indicate PR > 1, i.e. OLP-responses seen more frequently in individuals with reduced viral loads